Human SOX17 PharmaGenie ELISA Kit (SBRS1112)

The Human SOX17 PharmaGenie ELISA Kit from Assay Genie enables quantitative measurement of the SOX17 transcription factor across human biological samples. SOX17 is a key regulator of definitive endoderm specification during embryogenesis and is increasingly studied as a biomarker in oncology, where aberrant expression has been linked to gastric, colorectal, ovarian, and lung tumour progression, as well as in cardiovascular development and hematopoietic lineage commitment research.

The kit is supplied as a complete workflow with a pre-coated microplate, single-use vials of detection antibody and standards, and substrate solution, supporting reproducible in vitro quantification. Researchers investigating stem cell differentiation protocols can pair this assay with western blot and PCR workflows to monitor endodermal commitment stages, while reproductive biology and developmental biology labs use the human-specific capture antibody to characterise early embryonic patterning. For long-term studies, store unopened components refrigerated and avoid repeated freeze-thaw cycles of reconstituted standards to preserve assay performance.